Neovasc Provides Tiara(TM) Clinical Update

VANCOUVER, Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today provided an update on the study progress and clinical performance of the TiaraTM valve, a self-ex... Devices, Interventional, Cardiology Neovasc , Tiara valve, mitral bioprosthesis, mitral regurgitation

Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news